NEW YORK (GenomeWeb News) — UK proteomics shop NextGen Group has acquired protein identification-services company Proteomic Research Services for as much as $1.7 million in cash and stock, NextGen said today.
NextGen, eager to get a foothold in the US market, said it has acquired all of Ann Arbor, Mich-based PRS’ share capital for an initial payment of $498,000 and as much as $1.2 million more that will depend on PRS’ revenue over the next three years.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.